Marshall Wace North America’s Ascendis Pharma A/S ASND Stock Holding History

Marshall Wace North America’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$18M	Buy	113,146 +108,454	+2,311%	+$14.8M	0.08%	250
2021 Q2	$617K	Sell	4,692 -172,020	-97%	-$22.9M	﹤0.01%	1123
2021 Q1	$22.8M	Sell	176,712 -91,386	-34%	-$13.9M	0.09%	232
2020 Q4	$44.7M	Buy	268,098 +56,684	+27%	+$9.37M	0.2%	124
2020 Q3	$32.6M	Buy	211,414 +60,923	+40%	+$8.76M	0.21%	125
2020 Q2	$22.3M	Sell	150,491 -31,020	-17%	-$4.26M	0.15%	156
2020 Q1	$20.4M	Sell	181,511 -290,108	-62%	-$37.7M	0.15%	153
2019 Q4	$65.6M	Sell	471,619 -356,893	-43%	-$39.6M	0.32%	87
2019 Q3	$79.8M	Sell	828,512 -45,133	-5%	-$5.03M	0.45%	66
2019 Q2	$101M	Sell	873,645 -287,831	-25%	-$34.4M	0.62%	41
2019 Q1	$137M	Buy	1,161,476 +418,717	+56%	+$36.7M	0.97%	22
2018 Q4	$46.5M	Buy	742,759 +39,672	+6%	+$2.49M	0.45%	65
2018 Q3	$49.8M	Buy	703,087 +63,540	+10%	+$4.37M	0.34%	80
2018 Q2	$42.5M	Buy	639,547 +66,676	+12%	+$4.38M	0.24%	104
2018 Q1	$37.5M	Buy	572,871 +206,627	+56%	+$11.6M	0.19%	127
2017 Q4	$14.7M	Sell	366,244 -88,241	-19%	-$3.21M	0.08%	290
2017 Q3	$16.4M	Buy	454,485 +280,131	+161%	+$8.04M	0.1%	255
2017 Q2	$4.88M	Sell	174,354 -5,001	-3%	-$132K	0.04%	506
2017 Q1	$5.02M	Buy	+179,355	New	+$4.53M	0.04%	393

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Marshall Wace North America's ASND Position: Q3 2021 in Review

Marshall Wace North America increased its Ascendis Pharma A/S (ASND) stake by 2,311% in Q3 2021, buying an estimated $14.8M and bringing the position to 113,146 shares worth $18M. The position accounts for 0.08% of the portfolio, ranked #250.

Marshall Wace North America first reported a position in ASND in Q1 2017 and has held it in 19 quarters since. The position peaked at $137M in Q1 2019. 166 funds tracked by Wall St. Rank hold ASND as of Q3 2021.

Marshall Wace North America held 113,146 shares of Ascendis Pharma A/S worth $18M as of Q3 2021.
Marshall Wace North America bought 108,454 Ascendis Pharma A/S shares in Q3 2021, an estimated $14.8M.
Ascendis Pharma A/S made up 0.08% of Marshall Wace North America's portfolio in Q3 2021, its #250 holding.
Marshall Wace North America first reported a position in Ascendis Pharma A/S in Q1 2017 and has held it in 19 quarters since.
Marshall Wace North America's Ascendis Pharma A/S position peaked at $137M in Q1 2019.
166 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.